Cancer, Malaria & TB Vaccines
Malaria continues to claim an estimated 2 to 3 million lives annually and to account for untold morbidity in the approximately 300 to 500 million people infected annually. Malaria is considered a re-emerging disease, due largely to the spread of drug-resistant parasite strains, decay of health-care infrastructure and difficulties in implementing and maintaining vector control programs in many developing countries. Four species of protozoan parasites cause malaria in humans: Plasmodium falciparum, P. vivax, P. malariae, P. ovale and P. falciparum is responsible for the majority of deaths and most of the severe forms of disease, including cerebral malaria. 2 billion people latently infected with M. tuberculosis 5-10% infected people progress to disease 9 million new TB cases each year 1.5 million TB deaths each year Equivalent to 20 passenger aircraft crashes each day. TB is transmitted by adults with cavitatory disease, HIV infected people carry greater burden of disease. Highest risk of progression from TB infection to active disease, and worst TB morbidity and mortality, compared to older children and adults.
Related Conference of Cancer, Malaria & TB Vaccines
6th International Conference on Vaccines, Immunology and Clinical Trials
Cancer, Malaria & TB Vaccines Conference Speakers
Recommended Sessions
- Animal & Plant Derived Vaccines
- Animal Models & Clinical Trials
- Antibodies: Engineering & Therapeutics
- Cancer, Malaria & TB Vaccines
- Cellular Immunology & Latest Innovations
- Combination & Conjugate Vaccines
- Current Research & Future Challenges
- DNA & Synthetic Vaccines
- Fish & Poultry Vaccines
- Geriatric Immunization
- HIV Vaccines
- Paediatric Vaccination
- Travel & Edible Vaccines
- Vaccine Production & Development
- Vaccine Safety & Efficacy
- Vaccines
- Vaccines & Autism
- Vaccines against Drugs
- Vaccines Against Infectious Diseases
- Vaccines for Immune Mediated Diseases
- Vaccines for Pregnant Women & Neonates
- Vaccines for Unconventional Diseases
- Vectors, Adjuvants & Delivery Systems
- Veterinary Vaccines
Related Journals
Are you interested in
- Advancements of Vaccines - World Vaccines 2023 (France)
- Adverse effects of Vaccination - World Vaccines 2023 (France)
- Allergy & Asthma Vaccines - Vaccines R&D 2023 (Netherlands)
- Anti-bodies and Viral Diseases - World Vaccines 2023 (France)
- Antibiotics - World Vaccines 2023 (France)
- Antibodies Research - Vaccines R&D 2023 (Netherlands)
- Bio Markers and Case Reports - World Vaccines 2023 (France)
- Cancer and Tumor Immunobiology - Vaccine Immunology 2023 (Japan)
- Cancer Vaccines - VACCINE CONGRESS 2023 (Spain)
- Cancer, Malaria & TB Vaccines - Vaccine Immunology 2023 (Japan)
- Chicken pox Vaccines - VACCINE CONGRESS 2023 (Spain)
- Chicken Pox Vaccines - Vaccines R&D 2023 (Netherlands)
- Clinical Immunology & Immunopathology - Vaccines R&D 2023 (Netherlands)
- Clinical Trials - World Vaccines 2023 (France)
- Combination & Conjugate Vaccines - Vaccine Immunology 2023 (Japan)
- Component Vaccines - VACCINE CONGRESS 2023 (Spain)
- Corona Virus - World Vaccines 2023 (France)
- COVID-19 Vaccine - VACCINE CONGRESS 2023 (Spain)
- COVID-19 Vaccines - Vaccine Immunology 2023 (Japan)
- DNA & Synthetic Vaccines - Vaccine Immunology 2023 (Japan)
- Ebola Vaccines - VACCINE CONGRESS 2023 (Spain)
- Emerging and Infectious Diseases - Vaccine Immunology 2023 (Japan)
- Emerging Infectious Diseases - World Vaccines 2023 (France)
- Epidemiology in Public Health - Vaccine Immunology 2023 (Japan)
- Flu Vaccines - Vaccines R&D 2023 (Netherlands)
- Geriatric immunization - World Vaccines 2023 (France)
- HIV Vaccines - Vaccine Immunology 2023 (Japan)
- HIV Vaccines - VACCINE CONGRESS 2023 (Spain)
- HIV vaccines - World Vaccines 2023 (France)
- HIV Vaccines - Vaccines R&D 2023 (Netherlands)
- HPV Vaccines - Vaccines R&D 2023 (Netherlands)
- Human Papilloma Virus Vaccine - VACCINE CONGRESS 2023 (Spain)
- Human Vaccines Against Infectious Diseases - Vaccine Immunology 2023 (Japan)
- Human Vaccines-Infectious and Non-Infectious - Vaccine Immunology 2023 (Japan)
- Immune System Disorders - Vaccines R&D 2023 (Netherlands)
- Immunization and Bioprocessing - Vaccine Immunology 2023 (Japan)
- Immunization Challenges - Vaccines R&D 2023 (Netherlands)
- Immunization for pregnant & Lactating women - World Vaccines 2023 (France)
- Immunological Disorders - Vaccine Immunology 2023 (Japan)
- Immunology - World Vaccines 2023 (France)
- Immunology - Vaccines R&D 2023 (Netherlands)
- Infectious and Non-infectious diseases Vaccines - Vaccines R&D 2023 (Netherlands)
- MMR Vaccines - VACCINE CONGRESS 2023 (Spain)
- New Trends in Vaccines Development - Vaccine Immunology 2023 (Japan)
- Onco-Immunology - Vaccines R&D 2023 (Netherlands)
- Paediatric Vaccines - Vaccines R&D 2023 (Netherlands)
- Pathology and Immunology - Vaccine Immunology 2023 (Japan)
- Pediatric Immunology - Vaccines R&D 2023 (Netherlands)
- Pediatric Vaccines - Vaccine Immunology 2023 (Japan)
- Pediatric Vaccines - World Vaccines 2023 (France)
- Plant Vaccines & Veterinary Vaccines - Vaccines R&D 2023 (Netherlands)
- Plant-Based Vaccines - World Vaccines 2023 (France)
- Polio Vaccines - VACCINE CONGRESS 2023 (Spain)
- Preclinical Vaccine Studies - VACCINE CONGRESS 2023 (Spain)
- RDT in Antibotiic Research - Vaccine Immunology 2023 (Japan)
- Recombinant Vaccines - Vaccines R&D 2023 (Netherlands)
- Side-effects of Vaccines - Vaccine Immunology 2023 (Japan)
- Stem Cell Immunology - Vaccines R&D 2023 (Netherlands)
- Therapeutic Cancer Vaccines - Vaccines R&D 2023 (Netherlands)
- Toxoid Vaccines - Vaccine Immunology 2023 (Japan)
- Transplant Immunology - Vaccines R&D 2023 (Netherlands)
- Travel & Edible Vaccinations - Vaccines R&D 2023 (Netherlands)
- Travel Immunization - World Vaccines 2023 (France)
- Vaccine Adjuvants - VACCINE CONGRESS 2023 (Spain)
- Vaccine and Immunization - Vaccine Immunology 2023 (Japan)
- Vaccine Guidelines - World Vaccines 2023 (France)
- Vaccine Manufacturing Technologies - World Vaccines 2023 (France)
- Vaccine Production & Development - Vaccine Immunology 2023 (Japan)
- Vaccine Regulatory Issues - VACCINE CONGRESS 2023 (Spain)
- Vaccine Research & Development - VACCINE CONGRESS 2023 (Spain)
- Vaccine research and Development - World Vaccines 2023 (France)
- Vaccine Safety & Efficacy - Vaccine Immunology 2023 (Japan)
- Vaccine safety and Efficacy - World Vaccines 2023 (France)
- Vaccine Types - Vaccines R&D 2023 (Netherlands)
- Vaccine-Induced Immunity - Vaccines R&D 2023 (Netherlands)
- Vaccines - Vaccine Immunology 2023 (Japan)
- Vaccines - World Vaccines 2023 (France)
- Vaccines - Vaccines R&D 2023 (Netherlands)
- Vaccines and Immunology Advancements - Vaccines R&D 2023 (Netherlands)
- Vaccines and its types - World Vaccines 2023 (France)
- Vaccines Associated with Cancer - World Vaccines 2023 (France)
- Vaccines Efficacy and Safety - Vaccines R&D 2023 (Netherlands)
- Vaccines Epidemiology - VACCINE CONGRESS 2023 (Spain)
- Vaccines for Pregnant Women - Vaccine Immunology 2023 (Japan)
- Vaccines for Unconventional Diseases - Vaccine Immunology 2023 (Japan)
- Vaccines Immunology - VACCINE CONGRESS 2023 (Spain)
- Vaccines Manufacturing Technologies - Vaccine Immunology 2023 (Japan)
- Vaccines Research and Clinical Trails - Vaccine Immunology 2023 (Japan)
- Veterinary Vaccines and Animal Health - Vaccine Immunology 2023 (Japan)
- Viral Immunology - Vaccine Immunology 2023 (Japan)
- Viral Mutations and Variants - World Vaccines 2023 (France)
- Virology & Microbiology - World Vaccines 2023 (France)
- Zika Virus Vaccines - Vaccine Immunology 2023 (Japan)
- Zika Virus Vaccines - Vaccines R&D 2023 (Netherlands)